Ivermectin is available in multiple formulations, including topical creams, gels, lotions, and oral tablets. Pricing varies widely depending on the form, concentration, brand, country of purchase, and package size. Topical ivermectin is typically more expensive on a per‑gram basis due to specialized dermatologic formulations, while oral ivermectin tablets are generally more affordable and widely available in generic versions.
Brand‑name Soolantra (ivermectin 1% cream) is significantly more expensive than generic ivermectin creams or oral tablets, often costing several times more per unit. Understanding these price differences helps patients choose the most cost‑effective option for rosacea, Demodex, or parasitic indications. Explore related pricing resources: Ivermectin topical, Ivermectin cream 1%, Soolantra price.
The cost of ivermectin varies significantly depending on the formulation, concentration, and whether the product is branded or generic. In general, topical ivermectin (cream, gel, lotion) is more expensive per gram than oral ivermectin tablets, largely due to formulation complexity and dermatologic indications. Branded products such as Soolantra are priced substantially higher than generics, while generic oral ivermectin remains the most affordable option.
Topical formulations are typically used for rosacea and Demodex‑associated dermatoses. Prices vary by concentration (usually 1%), formulation type, and brand status. Branded Soolantra is the most expensive option, while generic ivermectin creams and gels offer more accessible pricing.
Oral ivermectin tablets are generally inexpensive due to widespread generic availability. Prices depend on strength (3 mg, 6 mg, 12 mg) and package size. These formulations are primarily used for parasitic infections rather than dermatologic conditions.
Brand‑name topical ivermectin (e.g., Soolantra) can cost several times more than generic equivalents. In contrast, oral ivermectin shows minimal price difference between brand and generic due to broad global production.
| Form | Concentration | Price range | Comment |
|---|---|---|---|
| Topical cream | 1% | Moderate–high | Branded Soolantra significantly more expensive |
| Topical gel/lotion | 1% | Moderate | Generic options cheaper than cream |
| Oral tablets | 3–12 mg | Low | Most affordable due to generic availability |
| Brand vs generic | Varies | Wide variation | Brand topical far higher than generic |
The cost of topical ivermectin varies widely depending on formulation type, concentration, brand status, and packaging volume. In dermatology, topical ivermectin is primarily used for rosacea and Demodex‑associated dermatoses, and its pricing reflects formulation complexity and cosmetic elegance. A detailed overview of cream formulations is available at Ivermectin cream 1%.
Generic 1% ivermectin cream is the most affordable topical option. Prices depend on tube size (15 g, 30 g, 45 g) and manufacturer. Generics typically offer:
Gel formulations are often priced slightly lower than creams due to simpler vehicles. They are preferred for oily or combination skin and may offer faster absorption but less moisturizing effect.
Lotion formulations (0.5–1%) are typically mid‑range in price. They provide lighter texture and better spreadability, making them suitable for larger areas. Pricing varies based on concentration and cosmetic quality of the vehicle.
| Form | Concentration | Price range | Comment |
|---|---|---|---|
| Cream | 1% | Moderate | Generic options significantly cheaper than Soolantra |
| Gel | 1% | Low–moderate | Often cheaper due to simpler formulation |
| Lotion | 0.5–1% | Moderate | Light texture; price varies by concentration |
The price gap between Soolantra (the branded ivermectin cream by Galderma) and generic ivermectin is one of the most significant in dermatology. While both contain ivermectin as the active ingredient, differences in formulation, vehicle quality, and brand positioning strongly influence cost. A detailed comparison is available at Ivermectin vs Soolantra.
Soolantra is positioned as a premium dermatologic product. Its higher price reflects:
As a result, Soolantra often costs several times more than generic ivermectin creams.
Generic ivermectin creams provide the same 1% active ingredient at a fraction of the cost. Differences include:
For many patients, generics offer excellent value without compromising therapeutic effect.
While both Soolantra and generics contain ivermectin 1%, the vehicle plays a major role in tolerability and user experience. Soolantra’s smoother, more hydrating base contributes to its premium pricing.
| Product | Concentration | Price range | Comment |
|---|---|---|---|
| Soolantra | 1% | High | Premium vehicle; dermatology‑grade formulation |
| Generic ivermectin cream | 1% | Low–moderate | Budget alternative with similar active ingredient |
| Generic gel/lotion | 0.5–1% | Low–moderate | Cheaper formulations; lighter texture |
The cost of oral ivermectin tablets is generally lower than topical formulations due to widespread global production and availability of multiple generics. Prices vary based on tablet strength (3 mg, 6 mg, 12 mg), package size, and manufacturer. Oral ivermectin is primarily used for parasitic infections, and its affordability contributes to its broad clinical adoption. More details on specific strengths are available at Ivermectin 3 mg tablets and Ivermectin 6 mg tablets.
The 3 mg strength is the most commonly used and typically the most affordable. Pricing depends on blister size (e.g., 2–20 tablets). Generics dominate this segment, keeping costs low.
6 mg tablets are moderately priced and often chosen for dosing convenience. They reduce pill burden compared to 3 mg tablets, which may slightly increase cost per tablet but not per milligram.
12 mg tablets are usually the highest‑priced per unit but may offer better value per milligram. They are preferred in regions where higher‑strength tablets simplify treatment logistics.
| Form | Strength | Price range | Comment |
|---|---|---|---|
| Tablets | 3 mg | Low | Most affordable; widely available generics |
| Tablets | 6 mg | Low–moderate | Higher strength; convenient dosing |
| Tablets | 12 mg | Moderate | Best value per mg; fewer tablets needed |
The cost of ivermectin varies not only by formulation but also by clinical indication. Dermatologic uses such as rosacea and Demodex infestation typically require topical formulations, which are more expensive per gram. Parasitic infections such as scabies and lice may require either topical or oral ivermectin, depending on severity and regional guidelines. More information is available at Ivermectin for rosacea, Ivermectin for demodex, Ivermectin vs Permethrin.
Rosacea treatment relies on topical ivermectin 1%. Prices are higher due to dermatology‑grade formulations and cosmetic vehicle quality. Branded Soolantra is the most expensive option, while generics offer more affordable alternatives.
Demodex‑associated dermatoses may require prolonged topical therapy. Costs depend on tube size and formulation type (cream, gel, lotion). Generic options significantly reduce long‑term expenses.
For scabies and lice, ivermectin may be used orally or topically. Oral ivermectin tablets are generally inexpensive, making them cost‑effective for widespread infestations. Topical ivermectin is more costly and typically reserved for resistant or sensitive‑skin cases.
| Indication | Preferred form | Price range | Comment |
|---|---|---|---|
| Rosacea | Topical 1% cream | Moderate–high | Branded Soolantra highest; generics cheaper |
| Demodex infestation | Topical 1% cream/gel | Moderate | Cost varies with duration and tube size |
| Scabies / lice | Oral tablets | Low | Most cost‑effective option for large‑area infestation |
The price of ivermectin varies widely across markets due to a combination of pharmaceutical, regulatory, and commercial factors. Understanding these variables is essential for comparing formulations, estimating treatment costs, and evaluating branded versus generic options. The following overview summarizes the primary determinants shaping ivermectin pricing across topical and oral forms.
Brand‑name products—especially dermatology‑grade formulations like Soolantra—are significantly more expensive due to proprietary vehicles, clinical trial investments, and marketing. Generics, by contrast, offer the same active ingredient at a fraction of the cost.
Higher concentrations (e.g., 1% topical vs 0.5%) typically cost more due to increased active ingredient content and stricter formulation requirements.
Topical creams are generally the most expensive due to complex cosmetic vehicles. Gels and lotions are moderately priced, while oral tablets remain the most affordable due to simple manufacturing and widespread generic availability.
Larger tubes or blister packs reduce the cost per gram or per tablet, although the upfront price is higher.
Prices vary significantly by region due to regulatory policies, import costs, and local manufacturing capabilities. Countries with strong generic industries typically offer lower prices.
Pharmaceutical companies may set premium prices for branded dermatology products, while generic manufacturers compete primarily on affordability.
| Factor | Impact |
|---|---|
| Brand vs generic | Brand significantly more expensive |
| Concentration | Higher % → higher price |
| Formulation | Cream > gel/lotion > tablets |
| Package size | Larger volume → lower cost per gram |
| Country of origin | Regulation & manufacturing affect price |
| Manufacturer policy | Premium pricing for branded dermatology products |
The cost of ivermectin varies considerably when compared to other topical treatments used for rosacea, Demodex infestation, and inflammatory dermatoses. Differences arise from formulation complexity, manufacturing costs, and therapeutic positioning. Detailed comparisons are available at: Ivermectin vs Benzyl benzoate, Ivermectin vs Azelaic acid, Ivermectin vs Metronidazole, Ivermectin vs Permethrin.
Metronidazole is typically cheaper than ivermectin, especially in generic gel or cream forms. However, ivermectin’s superior efficacy in Demodex‑associated rosacea often justifies its higher cost.
Azelaic acid is moderately priced but varies widely by brand. Some premium formulations approach the cost of ivermectin, while generics remain cheaper.
Benzyl benzoate is one of the cheapest antiparasitic topicals but is highly irritating and unsuitable for facial use. Ivermectin is more expensive but dramatically safer and more tolerable.
Permethrin is generally inexpensive, especially in 5% cream formulations. However, it is not optimized for rosacea and may cause irritation, making ivermectin a better‑tolerated but costlier option.
| Treatment | Typical price | Comment |
|---|---|---|
| Ivermectin | Moderate–high | Premium dermatology formulations increase cost |
| Metronidazole | Low–moderate | Cheaper; widely available generics |
| Azelaic acid | Moderate | Price varies by brand; some premium options |
| Benzyl benzoate | Very low | Cheap but highly irritating |
| Permethrin | Low | Inexpensive; not optimized for rosacea |
The economic efficiency of ivermectin is determined by the balance between its cost, duration of therapeutic effect, tolerability, and strength of clinical evidence. Across dermatologic and parasitic indications, ivermectin consistently demonstrates a favorable cost‑to‑benefit ratio, especially when compared with alternatives that require more frequent application, cause higher irritation, or offer less durable results.
Ivermectin provides a long‑lasting therapeutic effect, particularly in rosacea and Demodex‑associated dermatoses. Its prolonged skin retention and sustained anti‑inflammatory activity reduce flare frequency and minimize the need for repeated treatments. This makes ivermectin economically advantageous despite higher upfront costs compared with some generics or older therapies.
High tolerability translates into better adherence, reducing treatment failures and the need for switching therapies. Unlike azelaic acid or benzyl benzoate, ivermectin rarely causes irritation, which lowers the risk of discontinuation and additional dermatologic care. This stability enhances its long‑term economic value.
Ivermectin is supported by strong clinical data demonstrating superior efficacy in Demodex‑driven rosacea compared with metronidazole and better tolerability than azelaic acid. Its proven outcomes reduce the need for combination therapy or escalation to more expensive treatments, improving overall cost‑effectiveness.
| Economic factor | Impact |
|---|---|
| Duration of effect | Long‑lasting results reduce treatment frequency |
| Tolerability | High tolerability → fewer discontinuations |
| Clinical evidence | Strong efficacy reduces need for additional therapies |
| Overall value | Favorable cost‑to‑benefit ratio across indications |